Interaction of prion protein with acetylcholinesterase: potential pathobiological implications in prion diseases
The prion protein (PrP) binds to various molecular partners, but little is known about their potential impact on the pathogenesis of prion diseases. Here, we show that PrP can interact in vitro with acetylcholinesterase (AChE), a key protein of the cholinergic system in neural and non-neural tissues...
| Authors: | , , , , , , , , , , , |
|---|---|
| Format: | article |
| Status: | Published version |
| Publication Date: | 2015 |
| Country: | España |
| Institution: | Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| Repository: | Recercat. Dipósit de la Recerca de Catalunya |
| OAI Identifier: | oai:recercat.cat:2445/66823 |
| Online Access: | https://hdl.handle.net/2445/66823 |
| Access Level: | Open access |
| Keyword: | Amiloïdosi Malalties neurodegeneratives Proteïnes Amyloidosis Neurodegenerative Diseases Proteins |
| id |
ES_2530f7a8e1a0f7f07e2fd5dca0a0c9ea |
|---|---|
| oai_identifier_str |
oai:recercat.cat:2445/66823 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Interaction of prion protein with acetylcholinesterase: potential pathobiological implications in prion diseasesTorrent, JoanVílchez Acosta, Alba del ValleMuñoz-Torrero López-Ibarra, DiegoTrovaslet, M.Nachon, FlorianChatonnet, A.Grznarova, K.Acquatella-Tran Van Ba, I.Goffic, R. LeHerzog, LaetitiaBéringue, V.Rezaei, H.AmiloïdosiMalalties neurodegenerativesProteïnesAmyloidosisNeurodegenerative DiseasesProteinsThe prion protein (PrP) binds to various molecular partners, but little is known about their potential impact on the pathogenesis of prion diseases. Here, we show that PrP can interact in vitro with acetylcholinesterase (AChE), a key protein of the cholinergic system in neural and non-neural tissues. This heterologous association induced aggregation of monomeric PrP and modified the structural properties of PrP amyloid fibrils. Following its recruitment into PrP fibrils, AChE loses its enzymatic activity and enhances PrP-mediated cytotoxicity. Using several truncated PrP variants and specific tight-binding AChE inhibitors (AChEis), we then demonstrate that the PrP-AChE interaction requires two mutually exclusive sub-sites in PrP N-terminal domain and an aromatic-rich region at the entrance of AChE active center gorge. We show that AChEis that target this site impair PrP-AChE complex formation and also limit the accumulation of pathological prion protein (PrPSc) in prion-infected cell cultures. Furthermore, reduction of AChE levels in prion-infected heterozygous AChE knock-out mice leads to slightly but significantly prolonged incubation time. Finally, we found that AChE levels were altered in prion-infected cells and tissues, suggesting that AChE might be directly associated with abnormal PrP. Our results indicate that AChE deserves consideration as a new actor in expanding pathologically relevant PrP morphotypes and as a therapeutic target.BioMed Central2015201520152015info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion18 p.application/pdfhttps://hdl.handle.net/2445/66823Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésReproducció del document publicat a: http://dx.doi.org/10.1186/s40478-015-0188-0Acta Neuropathologica Communications, 2015, vol. 3, num. 18http://dx.doi.org/10.1186/s40478-015-0188-0cc-by (c) Torrent et al., 2015http://creativecommons.org/licenses/by/3.0/esinfo:eu-repo/semantics/openAccessoai:recercat.cat:2445/668232026-05-29T05:05:01Z |
| dc.title.none.fl_str_mv |
Interaction of prion protein with acetylcholinesterase: potential pathobiological implications in prion diseases |
| title |
Interaction of prion protein with acetylcholinesterase: potential pathobiological implications in prion diseases |
| spellingShingle |
Interaction of prion protein with acetylcholinesterase: potential pathobiological implications in prion diseases Torrent, Joan Amiloïdosi Malalties neurodegeneratives Proteïnes Amyloidosis Neurodegenerative Diseases Proteins |
| title_short |
Interaction of prion protein with acetylcholinesterase: potential pathobiological implications in prion diseases |
| title_full |
Interaction of prion protein with acetylcholinesterase: potential pathobiological implications in prion diseases |
| title_fullStr |
Interaction of prion protein with acetylcholinesterase: potential pathobiological implications in prion diseases |
| title_full_unstemmed |
Interaction of prion protein with acetylcholinesterase: potential pathobiological implications in prion diseases |
| title_sort |
Interaction of prion protein with acetylcholinesterase: potential pathobiological implications in prion diseases |
| dc.creator.none.fl_str_mv |
Torrent, Joan Vílchez Acosta, Alba del Valle Muñoz-Torrero López-Ibarra, Diego Trovaslet, M. Nachon, Florian Chatonnet, A. Grznarova, K. Acquatella-Tran Van Ba, I. Goffic, R. Le Herzog, Laetitia Béringue, V. Rezaei, H. |
| author |
Torrent, Joan |
| author_facet |
Torrent, Joan Vílchez Acosta, Alba del Valle Muñoz-Torrero López-Ibarra, Diego Trovaslet, M. Nachon, Florian Chatonnet, A. Grznarova, K. Acquatella-Tran Van Ba, I. Goffic, R. Le Herzog, Laetitia Béringue, V. Rezaei, H. |
| author_role |
author |
| author2 |
Vílchez Acosta, Alba del Valle Muñoz-Torrero López-Ibarra, Diego Trovaslet, M. Nachon, Florian Chatonnet, A. Grznarova, K. Acquatella-Tran Van Ba, I. Goffic, R. Le Herzog, Laetitia Béringue, V. Rezaei, H. |
| author2_role |
author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
Amiloïdosi Malalties neurodegeneratives Proteïnes Amyloidosis Neurodegenerative Diseases Proteins |
| topic |
Amiloïdosi Malalties neurodegeneratives Proteïnes Amyloidosis Neurodegenerative Diseases Proteins |
| description |
The prion protein (PrP) binds to various molecular partners, but little is known about their potential impact on the pathogenesis of prion diseases. Here, we show that PrP can interact in vitro with acetylcholinesterase (AChE), a key protein of the cholinergic system in neural and non-neural tissues. This heterologous association induced aggregation of monomeric PrP and modified the structural properties of PrP amyloid fibrils. Following its recruitment into PrP fibrils, AChE loses its enzymatic activity and enhances PrP-mediated cytotoxicity. Using several truncated PrP variants and specific tight-binding AChE inhibitors (AChEis), we then demonstrate that the PrP-AChE interaction requires two mutually exclusive sub-sites in PrP N-terminal domain and an aromatic-rich region at the entrance of AChE active center gorge. We show that AChEis that target this site impair PrP-AChE complex formation and also limit the accumulation of pathological prion protein (PrPSc) in prion-infected cell cultures. Furthermore, reduction of AChE levels in prion-infected heterozygous AChE knock-out mice leads to slightly but significantly prolonged incubation time. Finally, we found that AChE levels were altered in prion-infected cells and tissues, suggesting that AChE might be directly associated with abnormal PrP. Our results indicate that AChE deserves consideration as a new actor in expanding pathologically relevant PrP morphotypes and as a therapeutic target. |
| publishDate |
2015 |
| dc.date.none.fl_str_mv |
2015 2015 2015 2015 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/2445/66823 |
| url |
https://hdl.handle.net/2445/66823 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
Reproducció del document publicat a: http://dx.doi.org/10.1186/s40478-015-0188-0 Acta Neuropathologica Communications, 2015, vol. 3, num. 18 http://dx.doi.org/10.1186/s40478-015-0188-0 |
| dc.rights.none.fl_str_mv |
cc-by (c) Torrent et al., 2015 http://creativecommons.org/licenses/by/3.0/es info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
cc-by (c) Torrent et al., 2015 http://creativecommons.org/licenses/by/3.0/es |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
18 p. application/pdf |
| dc.publisher.none.fl_str_mv |
BioMed Central |
| publisher.none.fl_str_mv |
BioMed Central |
| dc.source.none.fl_str_mv |
Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica) reponame:Recercat. Dipósit de la Recerca de Catalunya instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| instname_str |
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| reponame_str |
Recercat. Dipósit de la Recerca de Catalunya |
| collection |
Recercat. Dipósit de la Recerca de Catalunya |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869404742736674816 |
| score |
15,811543 |